Omega Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -6.33 | -100% |
| P/S |
|
53.59 | 33.76 | 58.76% |
|
|
| P/BV |
|
2.86 | 4.82 | -40.71% |
|
|
| P/FCF |
|
-1.91 | 60.98 | -103.13% |
|
|
| Ev/Ebitda |
|
-2.42 | -22.12 | -89.08% |
|
|
| Ev/S |
|
72.98 | 22.56 | 223.44% |
|
|
| Ev/FCF |
|
-2.39 | 68.75 | -103.48% |
|
|
| E/P |
|
-0.5404 | 0.0178 | -3140.45% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3021.65 | 4.83 | -62655.39% | -17850.06 | -83.07% |
| ROE |
|
-167.93 | 9.61 | -1848.18% |
|
|
| ROA |
|
-47.67 | 0.3359 | -14292.47% |
|
|
| ROIC |
|
-106.29 | 7.63 | -1492.26% |
|
|
| ROS |
|
-3148.93 | -25.17 | 12410.59% |
|
|
| ROCE |
|
-172.82 | 15.33 | -1227.22% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.3229 | -3.67 | -91.19% | -0.3186 | 1.34% |
| Nеt Debt/Ebitda |
|
-0.6416 | -3.44 | -81.34% |
|
|
| Debt/Ratio |
|
0.1477 | 0.1972 | -25.08% |
|
|
| Debt/Equity |
|
7.19 | 1.65 | 336.51% |
|
|
| Debt/Net Income |
|
-0.3098 | 10.31 | -103.01% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
2048.61 | -56.89 | -3701% |
| Growth impulse Ebitda 5 years |
|
464.69 | -64.81 | -817% |
| Growth impulse Net Income 5 years |
|
441.27 | -58.33 | -856.51% |
| Growth impulse FCF 5 years |
|
455.17 | -47 | -1068.45% |
| Growth impulse EPS 5 years |
|
161.43 | -32.41 | -598.09% |
IP Score
4.3/10
